See more : China New Town Development Company Limited (1278.HK) Income Statement Analysis – Financial Results
Complete financial analysis of NanoGroup S.A. (NNG.WA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NanoGroup S.A., a leading company in the Biotechnology industry within the Healthcare sector.
- Archer Limited (ARHVF) Income Statement Analysis – Financial Results
- Toyoda Gosei Co., Ltd. (7282.T) Income Statement Analysis – Financial Results
- Green EnviroTech Holdings Corp. (GETH) Income Statement Analysis – Financial Results
- Ocugen, Inc. (OCGN) Income Statement Analysis – Financial Results
- Zheshang Development Group Co., Ltd (000906.SZ) Income Statement Analysis – Financial Results
NanoGroup S.A. (NNG.WA)
About NanoGroup S.A.
NanoGroup S.A. operates as a biotechnology company. It develops and licenses early-stage biotechnology and medical projects in the areas of oncology, transplantology, and blood donations to international biotech companies and pharmaceutical companies. NanoGroup S.A was incorporated in 2016 and is based in Warsaw, Poland.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|---|---|---|
Revenue | 2.02K | 139.55K | 492.49K | 687.51K | 351.83K | 110.29K | 40.80K | 0.00 | 7.40K |
Cost of Revenue | 81.04K | 95.78K | 185.90K | 31.18K | 18.25K | 25.55K | 86.85K | 58.40K | 6.01K |
Gross Profit | -79.02K | 43.77K | 306.60K | 656.32K | 333.58K | 84.74K | -46.05K | -58.40K | 1.39K |
Gross Profit Ratio | -3,913.67% | 31.36% | 62.25% | 95.46% | 94.81% | 76.83% | -112.87% | 0.00% | 18.80% |
Research & Development | 13.26M | 1.20M | 5.11M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 1.72M | 848.88K | 711.84K | 1.32M | 0.00 | 456.05K | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 3.25M | 839.05K | 1.72M | 848.88K | 711.84K | 1.32M | 48.91K | 456.05K | 447.13K |
Other Expenses | -75.05K | 825.91K | 1.66M | 3.07M | 1.33M | 1.17M | 1.97M | 476.40K | 0.00 |
Operating Expenses | 7.83M | 825.91K | 3.38M | 3.92M | 2.04M | 2.49M | 1.97M | 932.44K | 645.17K |
Cost & Expenses | 7.91M | 921.69K | 3.57M | 3.95M | 2.06M | 2.52M | 2.06M | 990.85K | 651.18K |
Interest Income | 240.00 | 1.37K | 3.00 | 31.80K | 39.05 | 1.97K | 3.09K | 20.91K | 72.40K |
Interest Expense | 515.00 | 1.37K | 5.18K | 31.80K | 51.38K | 19.33K | 24.31K | 20.91K | 0.00 |
Depreciation & Amortization | 35.41K | 62.19K | 64.35K | 156.57K | 215.21K | 55.32K | 54.17K | 30.54K | 24.76K |
EBITDA | -7.87M | -719.95K | -10.62M | -5.06M | -1.27M | -2.64M | -2.21M | -784.61K | -609.63K |
EBITDA Ratio | -389,809.76% | -515.91% | -1,118.94% | -742.17% | -424.59% | -2,129.07% | -4,798.35% | 0.00% | -8,234.88% |
Operating Income | -7.90M | -782.14K | -3.07M | -3.26M | -1.71M | -2.41M | -2.01M | -951.01K | -634.39K |
Operating Income Ratio | -391,377.22% | -560.48% | -624.12% | -474.76% | -485.77% | -2,181.02% | -4,935.76% | 0.00% | -8,569.34% |
Total Other Income/Expenses | -4.28K | 1.09K | -108.14K | -1.98M | 171.46K | -17.36K | -20.01K | 15.00K | -81.79K |
Income Before Tax | -7.91M | -783.51K | -10.69M | -5.24M | -1.54M | -2.42M | -2.03M | -936.01K | -716.18K |
Income Before Tax Ratio | -391,589.10% | -561.46% | -2,171.51% | -762.80% | -437.04% | -2,196.76% | -4,987.75% | 0.00% | -9,674.13% |
Income Tax Expense | 0.00 | -11.97K | -11.96K | 65.47K | 24.01K | -5.54K | -3.18K | -170.77K | 0.00 |
Net Income | -7.89M | -771.54K | -10.68M | -5.31M | -1.56M | -2.34M | -2.01M | -786.15K | -716.18K |
Net Income Ratio | -390,778.60% | -552.88% | -2,169.08% | -772.32% | -443.86% | -2,125.87% | -4,935.10% | 0.00% | -9,674.13% |
EPS | -0.39 | -0.05 | -0.64 | -0.32 | -0.11 | -0.18 | -0.16 | -0.07 | -0.47 |
EPS Diluted | -0.39 | -0.05 | -0.64 | -0.32 | -0.11 | -0.18 | -0.15 | -0.07 | -0.46 |
Weighted Avg Shares Out | 20.10M | 16.75M | 16.75M | 16.75M | 13.96M | 12.97M | 12.97M | 11.91M | 1.53M |
Weighted Avg Shares Out (Dil) | 20.10M | 16.75M | 16.75M | 16.75M | 13.96M | 13.03M | 13.03M | 11.97M | 1.54M |
Source: https://incomestatements.info
Category: Stock Reports